SVR12 Higher Than 97% in GT3 Cirrhotic Patients With Evidence of Portal Hypertension Treated With SOF/VEL Without Ribavirin: A Nation-Wide Cohort Study
Cells
doi 10.3390/cells8040313
Full Text
Open PDFAbstract
Available in full text
Date
April 4, 2019
Authors
Publisher
MDPI AG